Can a New Weight Loss Drug Burn Fat Faster Than Ozempic?
It’s worth the weight. A new injectable helps patients burn fat five times faster than Ozempic and Wegovy, according to the stunning results of a new clinical trial. The drug — currently known as VK2735 — was developed by California biotech company Viking Therapeutics, whose share price surged 80% after the trial results were announced Tuesday.
While the injectable still has to go through another clinical trial before becoming eligible for FDA approval, there’s already buzz that it could revolutionize the weight loss industry and leave other injectables in the dust. In the clinical trial, participants who were injected with a high dose of VK2735 once per week for 13 weeks lost an average of 32 pounds, or 14.7% of their body weight.
By comparison, it took patients injecting Ozempic and Wegovy 68 weeks — or five times as long — to see similar results. “Our plan is to proceed aggressively with further clinical development,” Viking CEO Brian Lian excitedly declared, saying the drug showed “promising efficacy.”
Excerpted from the New York Post
